<bill session="114" type="h" number="3666" updated="2017-06-02T21:34:24Z">
  <state datetime="2015-10-01">REFERRED</state>
  <status>
    <introduced datetime="2015-10-01"/>
  </status>
  <introduced datetime="2015-10-01"/>
  <titles>
    <title type="short" as="introduced">Scleroderma and Fibrosis Research Enhancement Act of 2015</title>
    <title type="official" as="introduced">To coordinate and advance fibrosis research activities at the National Institutes of Health, and for other purposes.</title>
    <title type="display">Scleroderma and Fibrosis Research Enhancement Act of 2015</title>
  </titles>
  <sponsor id="400219"/>
  <cosponsors>
    <cosponsor id="412565" joined="2016-05-10"/>
    <cosponsor id="400062" joined="2015-10-01"/>
    <cosponsor id="412571" joined="2015-10-28"/>
    <cosponsor id="412221" joined="2015-10-21"/>
    <cosponsor id="412271" joined="2016-09-08"/>
    <cosponsor id="400087" joined="2015-10-01"/>
    <cosponsor id="412544" joined="2016-11-15"/>
    <cosponsor id="412637" joined="2016-09-28"/>
    <cosponsor id="412420" joined="2016-09-22"/>
    <cosponsor id="400122" joined="2015-10-02"/>
    <cosponsor id="400124" joined="2016-06-14"/>
    <cosponsor id="400646" joined="2015-10-08"/>
    <cosponsor id="412453" joined="2015-10-28"/>
    <cosponsor id="400158" joined="2015-10-08"/>
    <cosponsor id="400160" joined="2016-09-14"/>
    <cosponsor id="412454" joined="2015-10-20"/>
    <cosponsor id="400170" joined="2016-03-23"/>
    <cosponsor id="412437" joined="2015-10-21"/>
    <cosponsor id="400195" joined="2015-10-21"/>
    <cosponsor id="412561" joined="2015-10-28"/>
    <cosponsor id="412546" joined="2016-09-22"/>
    <cosponsor id="412286" joined="2016-11-15"/>
    <cosponsor id="412557" joined="2015-12-01"/>
    <cosponsor id="412638" joined="2016-09-22"/>
    <cosponsor id="412616" joined="2016-06-10"/>
    <cosponsor id="400630" joined="2016-12-08"/>
    <cosponsor id="400245" joined="2016-09-09"/>
    <cosponsor id="412445" joined="2015-10-08"/>
    <cosponsor id="412521" joined="2016-06-15"/>
    <cosponsor id="412562" joined="2016-11-15"/>
    <cosponsor id="400263" joined="2015-10-06"/>
    <cosponsor id="412560" joined="2016-12-08"/>
    <cosponsor id="400276" joined="2015-11-16"/>
    <cosponsor id="408211" joined="2016-07-07"/>
    <cosponsor id="400295" joined="2015-10-01"/>
    <cosponsor id="412192" joined="2015-12-11"/>
    <cosponsor id="412307" joined="2015-12-15"/>
    <cosponsor id="400333" joined="2015-10-01"/>
    <cosponsor id="412647" joined="2016-04-14"/>
    <cosponsor id="400607" joined="2016-09-28"/>
    <cosponsor id="400360" joined="2016-11-29"/>
    <cosponsor id="400361" joined="2016-09-22"/>
    <cosponsor id="400378" joined="2015-10-20"/>
    <cosponsor id="412461" joined="2015-10-09"/>
    <cosponsor id="412520" joined="2016-01-12"/>
    <cosponsor id="400402" joined="2016-05-16"/>
    <cosponsor id="412319" joined="2015-10-20"/>
    <cosponsor id="412254" joined="2016-12-12"/>
    <cosponsor id="412548" joined="2015-10-21"/>
    <cosponsor id="412239" joined="2015-11-03"/>
    <cosponsor id="412412" joined="2016-06-10"/>
  </cosponsors>
  <actions>
    <action datetime="2015-10-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-10-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-10-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="114" type="s" number="3431"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Immunology and vaccination"/>
    <term name="Medical research"/>
    <term name="Musculoskeletal and skin diseases"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2015-10-01T04:00:00Z" status="Introduced in House">Scleroderma and Fibrosis Research Enhancement Act of 2015

This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.)

The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research.

The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness.

The commission must be terminated not later than two years after establishment.

The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan.</summary>
  <committee-reports/>
</bill>
